- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Transitional cell carcinoma of the urothelium
Total 452110 results
-
University of California, San FranciscoMerck Sharp & Dohme LLCWithdrawnInfiltrating Bladder Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage II Bladder Urothelial Carcinoma AJCC v6 and v7United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBladder CancerUnited States
-
Mansoura UniversityCompleted
-
Vanderbilt UniversityElement DiagnosticsCompletedBladder Cancer, BiomarkersUnited States
-
Seoul National University HospitalUnknown
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional...Canada
-
Medical University of South CarolinaTerminatedBladder CancerUnited States
-
Medical University of South CarolinaTerminated
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminatedBladder CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedFallopian Tube Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous Adenocarcinoma | Fallopian Tube Serous Adenocarcinoma | Malignant Ovarian Brenner Tumor and other conditionsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedRecurrent Bladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the BladderUnited States
-
Matthew GalskyCelgeneTerminatedBladder CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrial Mucinous Adenocarcinoma | Endometrial Mixed Adenocarcinoma | Endometrial...United States
-
Merrimack PharmaceuticalsUnknownSoft Tissue Sarcoma | Small Cell Lung Cancer | Ovarian Cancer | Squamous Cell Carcinoma of the Head and Neck | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Gastric Carcinoma | Solid Tumors | Pancreatic Ductal Adenocarcinoma | Endometrial Carcinoma | Urothelial Carcinoma | Prostate AdenocarcinomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)UnknownOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma and other conditionsUnited States
-
Corcept TherapeuticsCompletedSarcoma | Breast Cancer | Prostatic Neoplasms | Carcinoma, Transitional Cell | Prostate Cancer | Non-small Cell Lung Cancer | Ovarian Epithelial Cancer RecurrentUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnTransitional Cell Carcinoma | Infiltrating Bladder Urothelial Carcinoma | Stage II Bladder Urothelial Carcinoma
-
Seoul National University HospitalUnknownUrothelial CarcinomaKorea, Republic of
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrial Mucinous Adenocarcinoma | Endometrial Mixed Adenocarcinoma | Endometrial...United States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnInfiltrating Bladder Urothelial Carcinoma | Stage II Bladder Urothelial Carcinoma | Stage IV Bladder Urothelial Carcinoma | Stage III Bladder Urothelial CarcinomaUnited States
-
Endo PharmaceuticalsTerminatedCarcinoma in Situ | Transitional Cell Carcinoma | Non-muscle Invasive Bladder CancerUnited States
-
Asan Medical CenterKorean Cancer Study GroupUnknownTransitional Cell Carcinoma | Bladder Cancer | Ureter Cancer | Urethral CancerKorea, Republic of
-
Mirati Therapeutics Inc.CompletedUrothelial CarcinomaUnited States
-
Bioniche Life Sciences Inc.TerminatedCarcinoma in Situ | Neoplasm Recurrence, Local | Bladder Neoplasm | Mycobacterium | Transitional Cell, CarcinomaUnited States, Canada, Poland, Germany, Netherlands, United Kingdom
-
FKD Therapies OyCompletedSuperficial Bladder Cancer
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); OSI PharmaceuticalsCompletedBladder CancerUnited States
-
Mark Pomerantz, MDMerck Sharp & Dohme LLC; Rainier TherapeuticsTerminatedBladder CancerUnited States
-
Roswell Park Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI)TerminatedRecurrent Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Stage 0 Bladder Cancer | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
Asan Medical CenterKorean Cancer Study GroupUnknownTransitional Cell Carcinoma | Bladder Cancer | Ureter CancerKorea, Republic of
-
Southwest Oncology GroupNational Cancer Institute (NCI); University of Southern California; NCIC Clinical...TerminatedBladder CancerUnited States, Canada
-
DendreonTerminatedUrothelial CarcinomaUnited States
-
Oncolytics BiotechWithdrawnMuscle-invasive Transitional Cell Carcinoma of the Bladder
-
Association Pour La Recherche des Thérapeutiques...Roche Pharma AGCompletedRecurrent Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the BladderFrance, Belgium
-
National Cancer Institute (NCI)CompletedUrothelial Carcinoma | Ureteral Neoplasms | Ureter Cancer | Cancer of the Ureter | Neoplasm, UreteralUnited States
-
M.D. Anderson Cancer CenterFlight Attendant Medical Research InstituteCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); FKD Therapies Oy of FinlandCompleted
-
Sunnybrook Health Sciences CentreCelgene CorporationCompleted
-
Bristol-Myers SquibbCompletedUrothelial CarcinomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
Bioniche Life Sciences Inc.CompletedBladder NeoplasmsCanada, United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
KU LeuvenAgentschap voor Innovatie door Wetenschap en TechnologieCompletedBladder CancerBelgium
-
Sheba Medical CenterUnknownTransitional Cell CarcinomaIsrael
-
Noah Hahn, M.D.Pfizer; Hoosier Cancer Research NetworkTerminatedTransitional Cell Carcinoma of the BladderUnited States, United Kingdom
-
BIND TherapeuticsTerminatedCervical Cancer | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Urothelial CarcinomaRussian Federation, United States
-
Princess Al-Johara Al-Ibrahim Cancer Research CenterCompletedTransitional Cell Carcinoma of the BladderSaudi Arabia
-
Hoosier Cancer Research NetworkBristol-Myers SquibbCompletedTransitional Cell Carcinoma of the BladderUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
King Faisal Specialist Hospital & Research CenterCompleted
-
Daniel BernsteinCompletedSoft Tissue Sarcoma | Lymphoma, Non-Hodgkin | Leukemia | Breast Cancer | Myeloproliferative Disorders | Multiple Myeloma | Anemia | Pancreatic Cancer | Hodgkin Disease | Esophageal Cancer | Amyloidosis | Lung Cancer | Bone Cancer | Prostate Cancer | Neuroendocrine Tumors | Mesothelioma | Skin Cancer | Thyroid Cancer | Anal Cancer | Hepatobiliary Neoplasm and other conditionsUnited States